Gujarat Kidney And Super Speciality Financials

NSE: GKSL

₹181.25

₹3.43 (1.93%)

As on 18-Sep-2026IST

Market cap

₹1,432 Cr

Revenue (TTM)

₹101 Cr

P/E Ratio

90.4

P/B Ratio

5.6

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	101.04	40.24	4.77	--	--	--
Total Income	102.60	40.40	5.48	0.00	0.79	--
Total Expenditure	74.35	23.70	2.82	0.01	0.08	--
EBITDA	26.69	16.55	1.95	-0.01	-0.08	--
Depreciation	5.17	3.29	0.32	--	0.57	--
EBIT	21.52	13.26	1.63	-0.01	-0.65	--
Interest	2.36	0.65	0.07	--	--	--
Other Income	1.55	0.15	0.70	0.00	0.79	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	20.71	12.77	2.27	-0.01	0.14	--
Provision for Tax	3.98	3.27	0.55	--	0.04	--
Profit after Tax	16.73	9.50	1.71	-0.01	0.10	--
Minority Interest	-0.90	-0.09	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	15.84	9.41	1.71	-0.01	0.10	--

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	252.51	25.94	10.80	0.37	0.38	--
Minority Interest	-0.90	1.19	--	--	--	--
Non-Current Liabilities	15.09	5.85	5.46	-0.04	-0.04	--
Current Liabilities	27.82	21.69	4.24	3.50	3.50	--
Total Liabilities	297.64	55.34	20.53	3.87	3.88	--

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	120.22	32.83	13.77	2.67	2.67	--
Current Assets	104.59	21.84	6.73	1.15	1.16	--
Total Assets	297.64	55.34	20.53	3.87	3.88	--
Total Debt*	--	3.88	1.94	--	--	--
Net Current Assets	76.77	0.15	2.49	-2.34	-2.34	--
Contingent Liabilities	--	0.04	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	13.61	1.21	0.00	0.00	--
Cash Flow from Investing Activities	--	-18.14	0.22	--	--	--
Cash from Financing Activities	--	6.16	-0.47	--	--	--
Net Cash Inflow / Outflow	--	1.63	0.97	0.00	0.00	--

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	2.01	1.66	0.49	0.00	0.03	--
Cash EPS (₹)	2.01	2.25	0.58	0.00	0.19	--
Adjusted Book Value (₹)	32.70	4.56	0.50	0.11	0.11	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	2.39	60.64	0.01	0.11	--
Free Cash Flow per Share (₹)	--	-1.02	69.29	0.25	3.25	--

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	63.02	35.61	-1.66	36.31	--
ROE (%)	11.07	68.65	162.40	-1.66	26.56	--
ROA (%)	11.24	25.28	14.09	-0.16	2.61	--
EBIT Margin (%)	21.30	32.94	34.17	--	--	--
Net Margin (%)	16.31	23.52	31.29	-6,200.00	12.72	--
Cash Profit Margin (%)	--	31.78	42.59	--	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	118.51	742.89	--	--	--	--
EBIT Growth (%)	24.99	712.49	25,998.41	99.03	--	--
Net Profit Growth (%)	36.69	454.22	--	-106.20	--	--
EPS Growth (%)	4.54	238.16	--	-106.20	--	--
Book Value Growth (%)	--	1,390.08	370.18	-1.67	--	--

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	90.42	--	--	--	--	--
Price / Book Value	5.55	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	49.26	0.75	0.36	-31.69	0.28	--
Close Price (₹)	129.40	--	--	--	--	--
High Price (₹)	148.45	--	--	--	--	--
Low Price (₹)	98.25	--	--	--	--	--
Market Cap (₹ Cr)	1,431.79	--	--	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.01	0.15	1.12	--	--	--
Short term debt to equity ratio	--	0.05	--	--	--	--
Current Ratio	3.76	1.01	1.59	0.33	0.33	--
Quick Ratio	3.69	0.98	1.52	0.33	0.33	--
Interest Coverage	9.77	20.75	34.75	--	--	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	38.23	37.66	88.01	--	--	--
Asset Turnover	0.68	1.07	0.39	--	--	--
Receivable days	--	87.78	204.57	--	--	--
Inventory Days	--	4.29	20.64	--	--	--
Payable days	--	250.57	3,365.79	--	--	--
Cash Conversion Cycle	--	-158.50	-3,140.57	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.